These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 12838185

  • 21. [Updates on diagnosis and management of Kawasaki disease unresponsive to intravenous gamma globulin].
    Wang YQ, Cao XJ.
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):226-8. PubMed ID: 15833210
    [No Abstract] [Full Text] [Related]

  • 22. Refractory Kawasaki disease.
    Freeman AF, Shulman ST.
    Pediatr Infect Dis J; 2004 May; 23(5):463-4. PubMed ID: 15131473
    [No Abstract] [Full Text] [Related]

  • 23. Lessons from Kawasaki disease: all brands of IVIG are not equal.
    Stiehm ER.
    J Pediatr; 2006 Jan; 148(1):6-8. PubMed ID: 16423589
    [No Abstract] [Full Text] [Related]

  • 24. Macrophage activation syndrome in Kawasaki disease.
    Mukherjee D, Pal P, Kundu R, Niyogi P.
    Indian Pediatr; 2014 Feb; 51(2):148-9. PubMed ID: 24632699
    [Abstract] [Full Text] [Related]

  • 25. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids.
    Wright DA, Newburger JW, Baker A, Sundel RP.
    J Pediatr; 1996 Jan; 128(1):146-9. PubMed ID: 8551407
    [Abstract] [Full Text] [Related]

  • 26. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC, Aronoff SC.
    Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
    [Abstract] [Full Text] [Related]

  • 27. Infliximab as a novel therapy for refractory Kawasaki disease.
    Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS.
    J Rheumatol; 2004 Apr; 31(4):808-10. PubMed ID: 15088313
    [Abstract] [Full Text] [Related]

  • 28. [Immunoglobulin in suspected Kawasaki disease].
    García Soblechero E, Gómez Santos E, Domínguez Quintero ML, González Vila L.
    An Pediatr (Barc); 2010 Sep; 73(3):151-2. PubMed ID: 20605119
    [No Abstract] [Full Text] [Related]

  • 29. [Kawasaki syndrome in adults: treatment with polyvalent intravenous immunoglobulins].
    Pavese P, Brion JP, Meusnier T, Stahl JP.
    Ann Med Interne (Paris); 1997 Sep; 148(3):287-8. PubMed ID: 9255342
    [No Abstract] [Full Text] [Related]

  • 30. Cardiology patient pages. Kawasaki disease.
    Baker AL, Newburger JW.
    Circulation; 2008 Aug 12; 118(7):e110-2. PubMed ID: 18695195
    [No Abstract] [Full Text] [Related]

  • 31. Selective IgA deficiency complicated by Kawasaki syndrome.
    Nishikawa T, Nomura Y, Kono Y, Kawano Y.
    Pediatr Int; 2008 Dec 12; 50(6):816-8. PubMed ID: 19067898
    [No Abstract] [Full Text] [Related]

  • 32. A meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease.
    Chandelia S.
    Cardiol Young; 2015 Aug 12; 25(6):1228. PubMed ID: 25904322
    [No Abstract] [Full Text] [Related]

  • 33. Clinical trials in Kawasaki disease.
    Lehman TJ.
    Curr Rheumatol Rep; 2004 Dec 12; 6(6):415-6. PubMed ID: 15527699
    [No Abstract] [Full Text] [Related]

  • 34. Parotitis and kawasaki disease in a child with Noonan syndrome.
    Douvoyiannis M, Belamarich PF, Litman N.
    Pediatr Infect Dis J; 2008 Jan 12; 27(1):89-90. PubMed ID: 18162955
    [No Abstract] [Full Text] [Related]

  • 35. High-dose aspirin in Kawasaki disease.
    Shulman ST.
    J Pediatr; 1999 Apr 12; 134(4):523-4. PubMed ID: 10190936
    [No Abstract] [Full Text] [Related]

  • 36. Recent developments and controversies in Kawasaki disease.
    Guzman-Cottrill JA, Shulman ST.
    Minerva Pediatr; 2004 Feb 12; 56(1):51-61. PubMed ID: 15249914
    [Abstract] [Full Text] [Related]

  • 37. [Corticosteroids for treating Kawasaki disease].
    Calza AM.
    Ann Dermatol Venereol; 2001 Nov 12; 128(11):1276-7. PubMed ID: 11908186
    [No Abstract] [Full Text] [Related]

  • 38. Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.
    Khan S, Doré PC, Sewell WA.
    Pediatr Allergy Immunol; 2008 Mar 12; 19(2):186-7. PubMed ID: 18257907
    [No Abstract] [Full Text] [Related]

  • 39. Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease.
    Wada Y, Kamei A, Fujii Y, Ishikawa K, Chida S.
    J Pediatr; 2006 Mar 12; 148(3):399-400. PubMed ID: 16615977
    [Abstract] [Full Text] [Related]

  • 40. Macular oedema in Kawasaki syndrome.
    Garweg JG, Suter C, Aebi-Ochsner C, Villiger R.
    Graefes Arch Clin Exp Ophthalmol; 2012 Jul 12; 250(7):1101-4. PubMed ID: 22222924
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.